Takeda Remains A Buy, Boosted By Recent Narcolepsy Drug Approval And Robust Pipeline

Takeda's recent narcolepsy drug approval and robust pipeline boost its stock.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.